Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy

1990 ◽  
Vol 15 (3) ◽  
pp. 137-147 ◽  
Author(s):  
Pinuccia Valagussa ◽  
Milvia Zambetti ◽  
Gianni Bonadonna ◽  
Roberto Zucali ◽  
Guerrino Mezzanotte ◽  
...  
2010 ◽  
Vol 8 (3) ◽  
pp. 219
Author(s):  
A. Boukerche ◽  
C. Bechekat ◽  
A. Yahia ◽  
R. Madouri ◽  
M. Cherigane ◽  
...  

2012 ◽  
Vol 48 ◽  
pp. S55
Author(s):  
J. Galecki ◽  
M. Kolodziejczyk ◽  
W. Michalski ◽  
T. Pienkowski ◽  
Z. Mentrak ◽  
...  

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 624-624 ◽  
Author(s):  
Christian Jackisch ◽  
Winfried Schoenegg ◽  
Dietmar Arno Reichert ◽  
Manfred Welslau ◽  
Johannes Selbach ◽  
...  

2011 ◽  
Vol 47 ◽  
pp. S369
Author(s):  
J. Galecki ◽  
M. Kolodziejczyk ◽  
W. Michalski ◽  
T. Pienkowski ◽  
Z. Mentrak ◽  
...  

2011 ◽  
Vol 47 ◽  
pp. S374
Author(s):  
A. Boukerche ◽  
A. Yahia ◽  
M. Cherigane ◽  
M. Amri ◽  
K. Aissaoui ◽  
...  

2015 ◽  
Vol 1084 ◽  
pp. 406-408
Author(s):  
Zhanna Startseva ◽  
Ludmila Musabaeva ◽  
Valerij Lisin

The purpose of the study is to present the 10-year results of the combined modality treatment with the use of neutron-photon therapy for patients with T2-4N0-2M0 locally advanced breast cancer (LABC). The study involved 246 LABC patients (T2-4N0-2M0). Analysis of long-term results of multimodality treatment of patients with primary LABC has shown that preoperative neutron therapy is the most effective in the presence of multicentric tumors, radioresistance to neoadjuvant chemotherapy and other adverse prognostic factors.


Sign in / Sign up

Export Citation Format

Share Document